Vitamin Shoppe (VSI) Reports In-Line Q4 EPS

Vitamin Shoppe (NYSE: VSI) reported Q4 EPS of $0.41, in-line with the analyst estimate of $0.41. Revenue for the quarter came in at $290.1 million versus the consensus estimate of $294.77 million.

Total comparable sales grew 2.1%.

Vitamin Shoppe sees FY2015 EPS of $2.36-$2.46, versus the consensus of $2.51.

For earnings history and earnings-related data on Vitamin Shoppe (VSI) click here.

You May Also Be Interested In

• Gilead Sciences (GILD) Misses Q1 EPS by 288c
• Universal Logistics Holdings, Inc. (ULH) Tops Q1 EPS by 136c
• PTC Therapeutics (PTCT) Tops Q1 EPS by 9c, provides guidance